Podcasts about clinical guidelines

n this episode of Psychedelics Today, kicking of Psychedelic Science 2025 week in Denver, we sit down with Jonathan Dicksinson, Chief Executive Officer, and Trevor Millar, Chief Operations Officer of Ambio Life Sciences – one of the world's leading ibogaine clinics – to explore the potential of ibogaine for addiction, neuroregeneration, and how ethics, honoring experience, and sustainability will be key to delivering ibogaine at scale.  Trevor shares his early work supporting marginalized populations in Vancouver's Downtown Eastside, which led to the founding of Liberty Root, one of Canada's first ibogaine clinics. Jonathan reflects on his apprenticeship in Mexican clinics, years of international advocacy with the Global Ibogaine Therapy Alliance, and drafting the first set of clinical guidelines for ibogaine detoxification. Together with paramedic and ibogaine safety protocols expert Jose Inzunza, they co-founded Ambio in Tijuana in 2021. They discuss: The unique safety standards Ambio has pioneered – including industry-wide clinical protocols and magnesium therapy to mitigate cardiac risk. Their scale: over 3,000 patients treated, with 100+ clients per month across five dedicated houses in Baja California. Ambio's groundbreaking neuroregenerative program for Parkinson's, MS, and traumatic brain injury – which has already drawn patients like Brett Favre and Clay Walker. How ibogaine appears to drive profound physiological change – including evidence of TBI reversal as shown in Stanford's 2024 study on Special Forces veterans. Why ibogaine isn't just a molecule – it opens a long-lasting “critical period” of neuroplasticity that must be supported with preparation, integration, and holistic care. The deeper story of sourcing: through his company Terragnosis, Jonathan is the only person with a legal export license for Tabernanthe iboga from Gabon, and Ambio is setting a precedent for reciprocal and ethical global supply chains. Their cautionary perspective on Texas' $50M push toward ibogaine clinical trials – and why the traditional “one drug, one indication” model misses the complexity and promise of psychedelic healing. They also make a compelling case that Ambio is already modeling what the future of psychedelic care should look like – not a single drug in a sterile clinical setting, but a comprehensive, integrated protocol combining preparation, medical oversight, and deep integration. “Start with the end in mind,” Trevor urges – Ambio isn't just part of the movement; it's the blueprint for how ibogaine could be delivered worldwide. Links: Ambio Website: https://ambio.life/ Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis (Frontiers in Immunology, Feb 2025) Magnesium–ibogaine therapy in veterans with traumatic brain injuries (Nature Medicine, Jan 2024) Ibogaine reduced severe neuropathic pain associated with a case of brachial plexus nerve root avulsion (Frontiers in Pain Research, Aug 2023) Novel treatment of opioid use disorder using ibogaine and iboga in two adults (Journal of Psychedelic Studies, Jan 2020) Clinical Guidelines for Ibogaine-Assisted Detoxification Ambio Life Sciences Launches World's First Clinical Ibogaine Program for Patients With Neurodegenerative Conditions Bios:  Jonathan Dickinson is the Chief Executive Officer and Co-Founder of Ambio Life Sciences. One of the world's leading experts on ibogaine, Jonathan brings over 15 years of experience in clinical care, traditional practice, and psychedelic research to his leadership at Ambio. A Mexico-licensed psychologist and former Executive Director of the Global Ibogaine Therapy Alliance, he authored the field's foundational safety guidelines and has published widely on ibogaine's therapeutic, cultural, and ecological significance. He holds the only active export license for Tabernanthe iboga root, led the first Nagoya-compliant export from Gabon, and was initiated into the Dissoumba/Fang tradition of Bwiti in 2014 and the Missoko tradition in 2022. He has co-authored peer-reviewed research on ibogaine's potential for trauma, TBI, pain, MS, and Parkinson's. At Ambio, he leads strategy, research, and innovation – advancing a globally scalable model of care that bridges tradition, science, and integrity. Trevor Millar is the Chief Operating Officer and Co-Founder of Ambio Life Sciences. A social entrepreneur and pioneer in ibogaine advocacy and treatment, Trevor brings over a decade of experience supporting individuals through addiction recovery, trauma healing, and post-treatment integration. His background includes co-founding the Canadian Psychedelic Association and serving as Chair of the Board for MAPS Canada. He has co-authored peer-reviewed research on ibogaine's applications for trauma, TBI, and opioid use disorder, and has been featured in award-winning documentaries including DOSED and In Waves and War. Grounded in personal experience and guided by a philosophical approach to healing, Trevor is helping shape a new model for ethical, integrative psychedelic care on a global scale. At Ambio, Trevor leads operations, strategic partnerships, and client experience – bridging clinical care with systems design, education, and public advocacy.

In this episode, Dr. Jaclyn Smeaton and Dr. Kelly Ruef discuss the importance of education on perimenopause, a significant yet often overlooked phase in women's health. They explore the physiological changes that occur during this transition, the common symptoms women experience, and the need for effective hormone therapy.  This conversation also highlights:  The development of our new educational course, Perimenopause Management, aimed at helping practitioners better support women during perimenopause  Clinical gray areas surrounding perimenopause treatment options  The importance of understanding physiological changes during this stage How practitioners can support perimenopausal women through education and tailored treatment approaches  The need for comprehensive education in women's health, particularly regarding perimenopause Show Notes:Perimenopause Management is exclusive for registered DUTCH Providers. Get access by becoming a DUTCH Provider today or by logging in to the Provider Portal! 

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This short episode is about counselling patients on antidepressant medications.Hosts: Matthew Cho and Angad SinghAudio editing: Angad SinghTime Stamps:2:03 - Steps to antidepressant counselling7:31 - Frequently asked questions about antidepressantsRelated Episodes:PsychEd Episode 1: Diagnosis of Depression with Dr. Ilana ShawnPsychEd Episode 2: Treatment of Depression with Dr. Sidney KennedyPsychEd Episode 58: Depression in Children and Adolescents with Dr. Darren CourtneyPatient Education:UpToDate resource on ‘Medicines for Depression': https://www.uptodate.com/contents/medicines-for-depression-the-basicsCAMH resource on ‘Antidepressant Medications':https://www.camh.ca/en/health-info/mental-illness-and-addiction-index/antidepressant-medicationsKelty Mental Health resource on ‘Selective Serotonin Reuptake Inhibitors': https://keltymentalhealth.ca/sites/default/files/resources/SSRI_MedicationSheet2022.pdf, References:PsychDB. (2024, January 11). Introduction to Antidepressants. https://www.psychdb.com/meds/antidepressants/homeLam RW, Kennedy SH, Adams C, Bahji A, Beaulieu S, Bhat V, Blier P, Blumberger DM, Brietzke E, Chakrabarty T, Do A. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023: Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes. The Canadian Journal of Psychiatry. 2024 Sep;69(9):641-87.Contact:For more about PsychEd follow us on Instagram (@psyched.podcast),  Facebook (PsychEd Podcast), and X (@psychedpodcast). You can email us at psychedpodcast@gmail.com and visit our website at psychedpodcast.org.

In this episode, Dr. Zanotti discussed the Society of Critical Care Medicine “Focused Update on the Clinical Guidelines for the Prevention and Management of Pain, Anxiety. Agitation/Sedation. Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU." This is also known as the PADIS Guidelines. He is joined by Joanna L. Stollings, PharmD, a Board-Certified Pharmacotherapy Specialist and a Board-Certified Critical Care Pharmacotherapy Specialist. Joanna is the Medical Intensive Care Unit (MICU) Clinical Pharmacy Specialist at the Vanderbilt University Medical Center. She also served as vice chair for the PADIS Guideline Focused Update and co-authored the guidelines. Additional resources: Society of Critical Care Medicine Focused Update on the Clinical Guidelines for the Prevention and Management of Pain, Anxiety. Agitation/Sedation. Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. PADIS 2025 Update: https://pubmed.ncbi.nlm.nih.gov/39982143/ Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. PADIS 2018 Guidelines: https://pubmed.ncbi.nlm.nih.gov/30113379/ Link to a previous episode of Critical Matters discussing the PADIS 2018 Guidelines: https://soundphysicians.com/podcast-episode/?podcast_id=342&track_id=635606964 Landing page for the Critical Illness, Brain Dysfunction, and Survivorship (CIBS) Center: https://www.icudelirium.org/ Books mentioned in this episode: The Prophet. By Kahlil Gibran: https://bit.ly/4lA2Jhx

◆Voicy新チャンネル開設！【獣医Sara先生のペットの暮らしと健康】https://bit.ly/3sLljup【お知らせ

In this episode, Dr Brad Leech shares the exclusive results of his PhD research, which produced the first comprehensive clinical practice guidelines for intestinal permeability. Dispelling common myths about "leaky gut syndrome," Dr Leech explains why intestinal hyperpermeability is a legitimate physiological reaction—not a syndrome—and how his meticulously developed, evidence-based guidelines can transform clinical practice.This episode provides invaluable insights into the following:The rigorous methodology behind developing clinical practice guidelines, including stakeholder engagement, comprehensive literature review, and systematic evaluation of over 10,000 research articlesThe critical importance of risk-of-bias assessment when evaluating research—a cornerstone of methodology that helps practitioners look beyond cherry-picked studies and misleading claimsHow to systematically evaluate research quality by examining randomization procedures, analysis methods, conflict of interests and  clinical relevance rather than accepting published findings at face valueSurprising findings about commonly used interventions in intestinal permeability, including evidence that certain probiotics may not be effective for NSAID-induced permeability despite their widespread recommendationEvidence-based assessment of treatments for intestinal permeability using the NHMRC grading matrix to evaluate research qualityPractical recommendations and evidence-supported interventions that meet the threshold for clinical relevanceDr Leech's work represents a significant advancement in the field, bringing scientific rigour to an area often clouded by opinion and marketing claims. Learn how these new guidelines can help you make more informed clinical decisions and improve patient outcomes through evidence-based approaches to intestinal permeability.Connect with Dr Leech: Dr Brad LeechRead: The IP GuidelineGet in touch! Shownotes and references are available on the Designs for Health websiteRegister as a Designs for Health Practitioner and discover quality practitioner- only supplements at www.designsforhealth.com.au Follow us on Socials Instagram: Designsforhealthaus Facebook: Designsforhealthaus DISCLAIMER: The Information provided in the Wellness by Designs podcast is for educational purposes only; the information presented is not intended to be used as medical advice; please seek the advice of a qualified healthcare professional if what you have heard here today raises questions or concerns relating to your health

Doug Reynolds  Doug Reynolds is the author of The Road to Metabolic Health, the Founder and CEO of LowCarbUSA® and President of the Society of Metabolic Health Practitioners.    LowCarbUSA (now called Symposium of Metabolic Health) provides a platform for internationally renowned scientists and medical practitioners to present the ever-increasing body of evidence on the benefits of reducing carbohydrates in the diet and adding in healthy fats. It has now evolved into one of the primary resources for the low carb community.  This includes a huge library of educational videos, a growing database of practitioners and dietitians and sports trainers who are open to the carb reduction conversation as well as a searchable database for papers and articles covering the research into the evidence supporting this lifestyle.   The SMHP is a non-profit for practitioners focused on metabolic health and they have a panel of advisors to oversee the creation and maintenance of a set of ‘Clinical Guidelines for Therapeutic Carbohydrate reduction’ which was first published in May, 2019.  The SMHP also defines numerous pathways for accreditation and the forums encourage open discussion which helps to establish Standard of Care around carbohydrate reduction. Link to Show Notes on Website https://fabulouslyketo.com/podcast/228. Doug’s Book The Road to Metabolic Health: Why the Answer Lies in Food, Not Pharmaceuticals Resources Mentioned For a discount for Symposium of Metabolic Health Conferences use coupon code FABULOUSLYKETO for a 20% discount   The Journal of Metabolic Health Nutrition Network The SMHP scientific papers Connect with Doug Reynolds on social media X: https://twitter.com/lowcarbusa https://twitter.com/TheSMHP https://twitter.com/DougieReynolds https://twitter.com/LCPamDevine Facebook: https://www.facebook.com/pam.devine.961/ Facebook Page: https://www.facebook.com/LowCarbUSA https://www.facebook.com/TheSMHP Facebook Group:  https://www.facebook.com/groups/LowCarbUSACommunity Instagram: https://www.instagram.com/lowcarbusa/ https://www.instagram.com/thesmhp/ LinkedIn: https://www.linkedin.com/company/low-carb-usa/ https://www.linkedin.com/company/society-of-metabolic-health-practitioners/ https://www.linkedin.com/in/pam-devine-bab66721/ Website Details: https://www.lowcarbusa.org/ https://thesmhp.org/ The Fabulously Keto Diet & Lifestyle Journal: A 12-week journal to support new habits – Jackie Fletcher If you have enjoyed listening to this episode – Leave us a review By leaving us a review on your favourite podcast platform, you help us to be found by others. Support Jackie Help Jackie make more episodes by supporting her. If you wish to support her we have various options from one off donations to becoming a Super Fabulously Keto Podcast Supporter with coaching and support. Check out this page for lots of different ways to support the podcast. https://fabulouslyketo.com/support Or You can find us on Patreon: https://www.patreon. com/FabulouslyKeto Connect with us on social media https://www.facebook.com/FabulouslyKeto https://www.instagram.com/FabulouslyKeto1 https://twitter.com/FabulouslyKeto Facebook Group: https://www.facebook.com/groups/FabulouslyKeto Music by Bob Collum Recommend a guest We would love to know if you have a favourite guest you would like us to interview. Let us know who you would like to hear of if you have a particular topic you would like us to cover. https://fabulouslyketo.com/recommend-a-guest We sometimes get a small commission on some of the links, this goes towards the costs of producing the podcast.

On this episode of IPA's What, Why & How podcast, Kate Gainer welcomes Kyle Robb, PharmD, BCPS, Director of State Policy & Advocacy at ASHP, and Anna Legreid​​​​ Dopp, PharmD, CPHQ, Senior Director of Government Relations at ASHP, to discuss ASHP's top priorities and what's happening at the federal level. Kyle Robb, PharmD, BCPS, currently serves as Director of State Policy & Advocacy at the American Society of Health-System Pharmacists (ASHP). Kyle supports ASHP members and State Affiliates as they seek to advance the practice of pharmacy through engagement with state government. He is an alumnus of the Virginia Commonwealth University/American College of Clinical Pharmacy/American Society of Health-System Pharmacists Congressional Health Care Policy Fellow Program and served as a Health Policy Fellow on the staff of the U.S. Senate Committee on Health, Education, Labor & Pensions. Prior to working in policy, Kyle was a pharmacist at the University of Virginia Health System. Anna Legreid Dopp, PharmD, CPHQ, currently serves as Senior Director, Government Relations at the American Society of Health-System Pharmacists (ASHP). Previously, Anna served as Director of Clinical Guidelines and Quality Improvement at ASHP. Prior to this role, she served as Vice President of Public Affairs for the Pharmacy Society of Wisconsin (PSW) while practicing as a clinical pharmacist at the University of Wisconsin Hospital and Clinics. She also served as a Pharmacy Benefit Consultant with WEA Trust in Madison, WI and a Clinical Assistant Professor at the University of Wisconsin-Madison School of Pharmacy. Anna received her Doctor of Pharmacy from the University of Minnesota College of Pharmacy and served as a Congressional Health Policy Fellow with the United States Senate. Resources from today's episode: Action Alert: Residency Funding and the Rebuild America's Health Care Schools Act of 2024 ASHP Medication Shortages Webpage Action Alert: Oppose Site Neutral Proposals ASHP 340B Resources ASHP/ACCP/VCU Congressional Fellow Program ASHP on PBMs Podcast Series: Federal Trade Commission's Report on PBMs Specialty Steering White Bagging and Site of Care Restrictions Connect with us on LinkedIn: Kyle Robb Anna Legreid Dopp Kate Gainer Iowa Pharmacy Association

 We're combining education and relaxation in our final episode of Season 13! We're wrapping up our season with Zach Swartz, Perioperative Practice Specialist and Yoga Teacher. Tune in to learn more about how clinical guidelines are researched and developed, learn about the AORN Guideline for Tourniquet Safety, AND, learn more about incorporating yoga techniques into your day! Zach will even provide a short guided relaxation exercise for us, so don't miss it! #operatingroom #ornurse #scrubtech #surgicaltechnologist #perioperative #perioperativenurse #yoga #yogainnursing

DISCLAMER >>>>>>    The Ditch Lab Coat podcast serves solely for general informational purposes and does not serve as a substitute for professional medical services such as medicine or nursing. It does not establish a doctor/patient relationship, and the use of information from the podcast or linked materials is at the user's own risk. The content does not aim to replace professional medical advice, diagnosis, or treatment, and users should promptly seek guidance from healthcare professionals for any medical conditions.   >>>>>> The expressed opinions belong solely to the hosts and guests, and they do not necessarily reflect the views or opinions of the Hospitals, Clinics, Universities, or any other organization associated with the host or guests.       Disclosures: Ditch The Lab Coat podcast is produced by (Podkind.co) and is independent of Dr. Bonta's teaching and research roles at McMaster University, Temerty Faculty of Medicine and Queens University. Welcome to another episode of "Ditch the Lab Coat," the podcast where we critically explore the latest in medical science and healthcare with engaging discussions and a dose of skepticism. I'm your host, Dr. Mark Bonta, and today we have an insightful conversation lined up with our distinguished guest, Dr. Allan Detsky. Dr. Detsky, a professor at the University of Toronto and former Chief Physician at Sinai Health Systems, brings his extensive knowledge in evidence-based medicine, health policy, and clinical experience into our discussion.In this episode, we'll delve into the complex landscape of pain management and the opioid crisis, explore the future health challenges posed by climate change and societal shifts in civility, and critique the growing influence of unregulated health advice on social media. Dr. Detsky shares his candid views on the pharmaceutical industry's role in drug development, conflicts of interest, and the intricate relationship between lifestyle changes and medical advancements.We'll also discuss the limitations of evidence-based medicine, especially when it comes to treating patients with multiple conditions, and the challenges of applying clinical guidelines to real-world settings. Plus, stay tuned for an announcement about a website overhaul, launching in December, featuring expanded blog content for our curious listeners.Join us as we unravel these pressing issues and more, always questioning, always learning. "Ditch the Lab Coat" continues right now.00:00 - Podcast begins with healthcare insights from Dr. Alan Detsky.05:31 - Highlighting the role of randomized trials in improving evidence-based medicine.08:52 - Questioning the efficacy of zinc supplements for healthy young adults.10:27 - Clinical study results often fail to align with real patient demographics.16:57 - Lack of shared decision-making opportunities for hospitalized patients.19:22 - Discussing right-wing skepticism toward pharmaceutical companies, balanced with acknowledgment of their contributions.21:21 - Exploration of how pharmaceutical companies prioritize profits over public-interest-driven drug development.25:00 - Reflecting on personal and professional relationships with drug industry figures.30:43 - Increasing dependency on lifelong medications in healthcare.35:14 - Potential for AI to address systemic issues despite its resource demands.36:35 - Emphasizing the importance of verifying credentials to avoid unqualified healthcare professionals.

Dr. Jerry Brown, TIME Person of the Year, joins Mike Shanley to discuss Dr. Brown's work during the Ebola crisis, COVID-19 response and lessons learned for global pandemic preparedness, becoming TIME Person of the Year, and the role of international aid donors and implementing partners. Co-host: Care Africa Medical Foundation (CAMF) focuses on building clinics in rural Liberia, starting with their hometown of Buchanan in Grand Bassa County, where they have organized free health fairs to provide essential health resources. In addition to their nonprofit efforts, Henry and Gormah run successful businesses that cater to the aging population and assist the homeless in Colorado, creating over 60 local jobs. CAMF plans to open its first medical center in Grand Bassa County in the spring of 2025, addressing urgent healthcare needs. However, the lack of reliable electricity poses a significant challenge to operating medical equipment. As a registered 501(C)(3) organization, CAMF aims to make a lasting impact on healthcare in Africa and inspire others with its dedication to health and community service. https://www.linkedin.com/in/care-africa-medical-foundation-536206336/ https://www.camedfoundation.org/about/ Biography Jerry Fahnloe Brown was born on October 18, 1968. Dr. Brown has worked in several capacities as physician. He worked as Escort Doctor for MERCI on boats repatriating Sierra Leonean Refugees back to Sierra Leone. He then worked as the County Health Officer for Grand Bassa County and Medical Director for the Buchanan Government Hospital from 2006 to 2008 after working as a Volunteer Physician at the ELWA Hospital and General Practitioner from 2004 to 2006. In March 2014 he was employed as Medical Director and General Surgeon at the ELWA Hospital a position he held until February 2018 when he was appointed by the President of Liberia to serve as the Chief Medical Officer of the John F. Kennedy Medical Center, the premier teaching and referral hospital. During those years at ELWA, he worked tirelessly performing varieties of surgeries in this low resource setting. He became Clinical Supervisor and Clinician at the ELWA II Ebola Treatment Unit from July 2014 to June 2015. Under his leadership and guidance this unit produced the highest number of Ebola survivors changing the survival rate from ten percent to seventy percent of Ebola Patients at his Center. From October 2014 to December 2016, he served as Principal Investigator on two research projects with the Clinical Research Management on convalescent plasma and the sequelae of Ebola in survivors. In 2018, he was appointed by the President of Liberia as the Chief Executive Officer of the John F. Kennedy Medical Center, the premier referral hospital in Liberia, a position held until January 30, 2024, due to the political transition of power. While at JFKMC, he established the only active functional Intensive Care Unit in country with support from partners such as Project Cure International and NOCAL. Under his leadership JFKMC, obtained accreditation for training specialists in the areas of pediatrics, internal medicine, general surgery, ophthalmology and psychiatric. He also established the only histopathology unit; a state of the art executive private ward; a dialysis center among others. On May 23, 2019, he was elected Civilian Representative and Advisor to APORA. He also serves as Acting Faculty Head, Department of Surgery, A. M. Dogliotti College of Medicine for two years, and is currently a Part-Time Faculty member, in the Department of Surgery, Liberia College of Physician and Surgeon. In March 2020, he was appointed by the president of Liberia to serve as the Head of the National Case Management Pillar of COVID-19. He coordinated the management of COVID-19 patients across the country and the care of patients with COVID-19 vaccine related complications. He supervised the drafting of Liberia COVID-19 Clinical Guidelines. Dr. Brown has received many honors to include, Time Person of the Year in 2014; among Time 100 Most Influential Persons, 2014; Civil Servant of the Year, 2014, Republic of Liberia; President of Liberia Highest Honor, Star of Africa in 2015; Golden Key Awards, 2018; He has spoken as several places to include Keynote Speaker, PICC 2016, 8th World Congress on Pediatric Intensive and Critical Care, Toronto Canada, June 2016; keynote Speaker, Case Western University, Ohio, October 2015; Keynote Speaker, Risky Business Conference, London, UK, May 2017; Speaker, American Society of Tropical Medicine and Hygiene, (ASTMH) 64TH Annual Meeting, ASTMH Ebola 360 symposium, October 2015; Pepperdine University, Dean Honorary Speaker—Leadership June 2017.    Thank you for tuning into this episode of the Aid Market Podcast. Learn more about working with USAID by visiting our homepage: Konektid International and AidKonekt. To connect with our team, message the host Mike Shanley on LinkedIn  

A troubling disconnect between medical expertise and insurance mandates is putting patients' health at risk. Policies like step therapy and prior authorization are forcing individuals into treatments not recommended by their doctors—often with devastating consequences. In this episode, we hear from a patient who endured months of suffering due to her insurer's 'fail-first' requirements. We also talk with a doctor navigating this impossible system and a biotech leader fighting to ensure innovative treatments reach the patients who need them most. Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/

Evaluation and Credit:  https://www.surveymonkey.com/r/Medchat72 Target Audience This activity is targeted toward primary care physicians and advanced providers. Statement of NeedAdolescents with Type 1 diabetes mellitus (T1DM) face a significantly higher risk of developing cardiovascular disease (CVD) compared to their peers without diabetes. Regular physical activity is crucial for these young individuals, as it helps mitigate CVD risk and improves cardiorespiratory fitness (CRF). Therefore, promoting lifelong physical activity, with appropriate insulin and dietary adjustments, is essential for managing T1DM and preventing CVD. This podcast will highlight the benefits of exercise in preventing cardiovascular disease, describe the advantages of sports activities, and outline clinical guidelines for safe exercise practices in adolescents with T1DM. Objectives At the conclusion of this offering, the participant will be able to:  Discuss the benefits of exercise in the management of adolescent patients with Type 1 diabetes.  Describe potential glycemic management strategies during times of sport/activity in adolescents with Type 1 diabetes. Review the role of technology and future advancements in the management of diabetes.  Moderator Mark McDonald, M.D., MHA, CPE System Vice President Pediatric Medical Affairs Medical Director, Norton Children's Louisville, Kentucky  Professor Department of Pediatrics Division of Critical Care UofL School of Medicine Louisville, Kentucky Speaker Brad Thrasher, D.O., MBAPediatric Endocrinologist Medical Director, Pediatric Diabetes Medical Director, Sport & Activity Wendy Novak Diabetes Institute Norton Children's Endocrinology Louisville, Kentucky Associate Professor UofL School of Medicine Louisville, Kentucky    Moderator, Speaker and Planner Disclosures  The planners, moderator and speaker of this activity do not have any relevant financial relationships with ineligible companies to disclose.   Commercial Support  There was no commercial support for this activity.  Physician Credits Accreditation Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians. Designation Norton Healthcare designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.   For more information about continuing medical education, please send an email to cme@nortonhealthcare.org.  Nursing CreditaNorton Healthcare Institute for Education and Development is approved with distinction as a provider of nursing continuing professional development by the South Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. This continuing professional development activity has been approved for .50 contact hours. In order for nursing participants to obtain credits, they must claim attendance by attesting to the number of hours in attendance.   For more information related to nursing credits, contact Sally Sturgeon, DNP, RN, SANE-A, AFN-BC at (502) 446-5889 or sally.sturgeon@nortonhealthcare.org. Resources for Additional Study/References Chang, Xinyi, et. Al.  “Effect of Physician Activity/Exercise on Cardiorespiratory Fitness in Children and Adolescents with Type I Diabetes: A Scoping Review”; International Journal of Environmental Research and Public Health, Jan. 12, 2023; https://doi.org/10.3390/ijerph20021407 Cockcroft et al. “Factors affecting the support for physical activity in children and adolescents with type 1 diabetes mellitus: a national survey of health care professionals' perceptions”; BMC Pediatrics (2023) 23:131. https://doi.org/10.1186/s12887-023-03940-3   Date of Original Release | Nov. 2024; Information is current as of the time of recording. Course Termination Date | Nov. 2026 Contact Information | Center for Continuing Medical Education; (502) 446-5955 or cme@nortonhealthcare.org Also listen to Norton Healthcare's podcast Stronger After Stroke. This podcast, produced by the Norton Neuroscience Institute, discusses difficult topics, answers frequently asked questions and provides survivor stories that provide hope. Norton Healthcare, a not for profit health care system, is a leader in serving adult and pediatric patients throughout Greater Louisville, Southern Indiana, the commonwealth of Kentucky and beyond. More information about Norton Healthcare is available at NortonHealthcare.com.

Avec Dr Philippe Major, neurologue pédiatrique, et Marianne Boulé, pharmacienne au CHU Sainte-Justine, nous allons:Partie 1:définir l'épilepsie et l'impact qu'elle a sur la vie des patients ;distinguer les convulsions provoquées de celles non-provoquées ;discuter des principales lignes de traitements pharmacologiques ;Partie 2: expliquer les principes de la diète cétogène chez les patients vivant avec une épilepsie réfractaire ;identifier les médicaments qui doivent être évités en diète cétogène ;résumer les traitements chirurgicaux et la neuromodulation ;Références:Turgeon, J. et coll. Dictionnaire de pédiatrie Weber. 3e édition chapitre 89 épilepsie. p.445-456. Épilepsie : Soins et services [Internet] - Parlons d'épilepsie. CHU Sainte-Justine. 2024. Protocoles urgence HSJ. Convulsion - épilepsie, status epilepticus. 2023 Société canadienne de pédiatrie. La prise en charge d'urgence du patient pédiatrique en état de mal épileptique convulsif. Février 2021 Anthony Fine, Elaine C. Wirrell; Seizures in Children. Pediatr Rev July 2020; 41 (7): 321–347. Minardi C et coll. Epilepsy in Children: From Diagnosis to Treatment with Focus on Emergency. J Clin Med. 2019 Jan 2;8(1):39.Ontario Epilepsy Guidelines. Clinical Guidelines for the Management of Epilepsy in Adults and Children. 2020 Formation Université Laval épilepsie pédiatrique: osez vous impliquer (disponible jusqu'au 31 déc. 2024) par Geneviève Laflamme, pharmacie du CHU de QuébecInternational League Against EpilepsyAmerican Epilepsy SocietyMerci pour l'écoute! Allez mettre une réaction sur vos épisodes préférés, partagez la bonne nouvelle sur Facebook/Instagram et abonnez-vous pour ne rien manquer

Dr. Yair Saperstein, CEO of Avo, discusses how winning the American Heart Association's Health Tech Competition catapulted their AI-powered clinical decision support tool into the spotlight. Learn how Avo is revolutionizing cardiac care and beyond, leveraging their AHA recognition to drive innovation in healthcare technology. Dr. Yair Saperstein, CEO, AvoMegan Antonelli, CEO, HealthIMPACT

Send us a Text Message.Doug Reynolds is a returning guest on our show! Be sure to check out his first appearance on episode 532 of Boundless Body Radio! Doug Reynolds is the Founder and CEO of LowCarbUSA®. The original organization was founded in the beginning of 2016 with the initial intention of providing  a platform, through an annual conference, for internationally renowned scientists and medical practitioners to present the ever-increasing body of evidence on the benefits of reducing carbohydrates in the diet. Doug has also coordinated the establishment of a panel of advisors to oversee the creation and maintenance of a set of 'Clinical Guidelines for Therapeutic Carbohydrate Reduction' which was first published in 2019. Currently, Doug is the president of the Society of Metabolic Health Practitioners (SMHP™), and this organization now provides education and training of Metabolic Health Practitioners, and serves those who are interested in making a difference in worldwide metabolic health.  The aim is to stall and reverse the increasing prevalence of chronic diseases, influenced by metabolic dysfunction and insulin resistance.Find Doug at-https://www.lowcarbusa.org/https://thesmhp.org/IG- @lowcarbusaTW- @lowcarbusaFind Boundless Body at- myboundlessbody.com Book a session with us here!

The Surgical Management of BPH and Updates from the AUA Clinical Guidelines Podcast (2024) CME Available: https://auau.auanet.org/node/41595 ACKNOWLEDGEMENT: This educational series is supported by an independent educational grant from Olympus Corporation of the Americas. At the conclusion of this activity, participants will be able to:   1. Describe the role of the AUA Clinical Guideline on the Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia. 2. Discuss the evidence base for current technologies, including pivotal studies, and be able to define the role and clinical expectation for each of them. 3. Interpret the current clinical results and compare the patient experiences of these treatments in relation to more established and even abandoned treatments for patient groups with similar characteristics. 4. Differentiate between each of the new technologies for treating BPH/LUTS based on both their mode-of-action and the quality of their supporting evidence.

Listen to Diana Rubledo Ruiz talk about applying genetics to conservation and comedy - part 1. News of new Clinical Guidelines for ME/CFS. Hosted and produced by Ian Woolf Support Diffusion by making a contribution Support Diffusion by buying Merchandise

This podcast summarises the BEVA primary care clinical guidelines on equine parasite control by David Rendle et al.   

Doug Reynolds and Pam Devine  When Pam Devine turned 47 she was super excited that she had found something that helped her to lose the weight that she had put on since turning 40. Up until that point no matter what she did she couldn't lose it.  Pam felt she worked out more than many of the people she encountered during her workday and was getting super frustrated with her failure to keep her weight under control.   Once she and her partner Doug Reynolds found keto and changed their way of eating the weight dropped away and she found peace of mind, feeling totally satiated and more focused than she has ever been. Best yet, the ups and downs of blood sugar roller coaster have calmed and she feels like she found food freedom, lowering her growing anxiety of not knowing what to eat for health. Now with Doug, Pam hosts the Low Carb USA events that bring together medical professionals and experts in the low carb / keto / carnivore world to share their knowledge and the latest research with other health professionals and non-healthcare people. They are working towards halting the catastrophic rise in obesity, type 2 diabetes, and other chronic diseases that we’ve seen since 1977. Pam is also one of the key Founding Members and Volunteers of The Society of Metabolic Health Practitioners. Doug Reynolds is the Founder and CEO of LowCarbUSA® and President of the Society of Metabolic Health Practitioners.   LowCarbUSA (now called Symposium of Metabolic Health) provides a platform for internationally renowned scientists and medical practitioners to present the ever-increasing body of evidence on the benefits of reducing carbohydrates in the diet and adding in healthy fats. It has now evolved into one of the primary resources for the low carb community.  This includes a huge library of educational videos, a growing database of practitioners and dietitians and sports trainers who are open to the carb restriction conversation as well as a searchable database for papers and articles covering the research into the evidence supporting this lifestyle.   The SMHP is a non-profit for practitioners focused on metabolic health and they have a panel of advisors to oversee the creation and maintenance of a set of ‘Clinical Guidelines for Therapeutic Carbohydrate Restriction’ which was first published in May, 2019.  The SMHP also defines numerous pathways for accreditation and the forums encourage open discussion which helps to establish Standard of Care around carbohydrate restriction. Link to Show Notes on Website https://fabulouslyketo.com/podcast/190. Doug Reynold’s and Pam Devine Top Tips Pam Top Tips Keep your cooking simple. If you are struggling to start or stick to it – look at food addiction and get some help. If you can tolerate them – make substitutions Doug Top Tips Be open minded and don't be dogmatic. Help people who are interested in keto to be successful. Be supportive – don't be judgmental of people who say it is too hard or can't get started. Resources Mentioned For a discount for Symposium of Metabolic Health use coupon code FABULOUSLYKETO for a 20% discount The Journal of Metabolic Health Nutrition Network Ketogenic: The Science of Therapeutic Carbohydrate Restriction in Human Health – Tim Noakes, Tamzyn Murphy, Neville Wellington and more  The SMHP scientific papers Dave Feldman – Citizen Science 164: Dr Laura Buchannan – Ageing Successfully 181: Dr Matt Calkins – Prevention Better Than Cure PHC UK Conference 086: Carrie Brown – Chow, Cooking, Cats and Cameras 162: Dr Bret Scher – Metabolic Mind for Improving Mental Health 185: Kent Bray – Messages of Hope From A Cocaine Addict 166: Anna Frueling – Addiction Is A Disease Fat Fiction Connect with Doug Reynolds and Pam Devine on social media Twitter: https://twitter.com/lowcarbusa Facebook: https://www.facebook.com/pam.devine.961/ Facebook Page: https://www.facebook.com/LowCarbUSA https://www.facebook.com/TheSMHP Facebook Group: https://www.facebook.com/groups/LowCarbUSACommunity Instagram: https://www.instagram.com/lowcarbusa/ https://www.instagram.com/thesmhp/ LinkedIn: https://www.linkedin.com/company/low-carb-usa/ https://www.linkedin.com/company/society-of-metabolic-health-practitioners/ https://www.linkedin.com/in/pam-devine-bab66721/ Website Details: https://www.lowcarbusa.org/ https://thesmhp.org/ The Fabulously Keto Diet & Lifestyle Journal: A 12-week journal to support new habits – Jackie Fletcher If you have enjoyed listening to this episode – Leave us a review By leaving us a review on your favourite podcast platform, you help us to be found by others. Support Jackie Help Jackie make more episodes by supporting her If you wish to support her by just pledging £1 or £2 a month go to: https://fabulouslyketo.thrivecart.com/support-the-podcast/ Or You can get some extra benefits by supporting her on Patreon: https://www.patreon.com/FabulouslyKeto Connect with us on social media https://www.facebook.com/FabulouslyKeto https://www.instagram.com/FabulouslyKeto1 https://twitter.com/FabulouslyKeto Facebook Group: https://www.facebook.com/groups/FabulouslyKeto Music by Bob Collum Recommend a guest We would love to know if you have a favourite guest you would like us to interview. Let us know who you would like to hear of if you have a particular topic you would like us to cover. https://fabulouslyketo.com/recommend-a-guest We sometimes get a small commission on some of the links, this goes towards the costs of producing the podcast.

Join Gaining Health host, Karli Burridge, PA, FOMA, as she discusses the newest Clinical Practice Statement (CPS) for Adolescents with Obesity published by the Obesity Medicine Association (OMA).  The rates are alarming, and clinician education on best care practices is vital.   While treatment can be complex with various influences, treatment starting at the onset leads to the best outcomes.  Link to Article HereLink to "AAP's Clinical Guidelines for Pediatric Obesity" on Spotify or Apple PodcastsSupport the showThe Gaining Health Podcast will release a new episode monthly, every second Wednesday of the month. Episodes including interviews with obesity experts as well as scientific updates and new guidelines for the management of obesity.If you're a clinician or organization looking to start or optimize an obesity management program, and you want additional support and resources, check out the Gaining Health website! We offer monthly and annual Memberships, which include live group coaching, a community forum to ask questions and post resources, pre-recorded Master Classes, digital resources inlcuding patient education materials and office forms, and much more! We also sell our popular Gaining Health products, including a book on developing an obesity management program, editable forms and templates, and patient education materials in our Gaining Health Shop! If you are loving this podcast, please consider supporting us on Patreon

❌❌❌در قسمت صد و بیست و‌چهار دنتکست، مقاله ی قبلی رو ادامه میدیم و به اتمام میرسونیماین مقاله گایدلاینهای کلینیکی ای برای بازسازی دندانهای خلفی ارائه میده.این گایدلاینها در مورد اینه که با توجه به میزان تخریب، دندونها به چه شکل و با چه نوع رستوریشنی بازسازی بشنمقاله ی جدید و جالبیه ،حتما گوش‌کنید.

❌❌❌در قسمت صد و بیست و‌سوم دنتکست، مقاله ی قبلی رو ادامه میدیم.این مقاله گایدلاینهای کلینیکی ای برای بازسازی دندانهای خلفی ارائه میده.این گایدلاینها در مورد اینه که با توجه به میزان تخریب، دندونها به چه شکل و با چه نوع رستوریشنی بازسازی بشنمقاله ی جدید و جالبیه ،حتما گوش‌کنید.

❌❌❌در قسمت صد و بیست و‌دوم دنتکست، مقاله ی قبلی رو ادامه میدیم.این مقاله گایدلاینهای کلینیکی ای برای بازسازی دندانهای خلفی ارائه میده.این گایدلاینها در مورد اینه که با توجه به میزان تخریب، دندونها به چه شکل و با چه نوع رستوریشنی بازسازی بشنمقاله ی جدید و جالبیه ،حتما گوش‌کنید.

In this episode, Ryan dives into cutting-edge research on the treatment of acetaminophen (APAP) overdose, featuring interviews with authors of several key abstracts from the North American Congress of Clinical Toxicology (NACCT) in Montreal Canada (Abstracts and posters available in the show notes). We get first looks insights into research evaluating the impact of fomepizole high risk acetaminophen overdose, as well as who gets fomepizole for acetaminophen overdose and dies. Then we evaluate the effectiveness of standard N-acetylcysteine (NAC) treatment in high risk patients and high dose NAC in high risk patients. Join us for an insightful discussion on these advancements that are reshaping the management of APAP toxicity. Guests include Dr. Masha Yemets PharmD, Dr. Molly Stott PharmD, Dr. Alexandru Ulici PharmD, and Dr. Michael Moss MD.   Link to published abstracts(First guest) Abstract #126 Characterizing fomepizole use in acetaminophen deaths reported to US poison centers- Dr. Yemets(Second guest) Abstract #125 Clinical impact of fomepizole as an adjunct therapy in massive acetaminophen overdose- Dr. Stott(Third guest) Abstract #131 Comparison of low-risk and high risk acetaminophen ingestions using the standard prescott protocol of intravenous N-acetylcysteine- Dr. Ulici(Fourth guest) Abstract #130 High-risk acetaminophen overdose outcomes after treatment with standard dose vs. increased dose N-acetylcysteine- Dr. MossOther studies discussed regarding NAC dosingATOM 2 Angela ChiewOutcomes of massive APAP treated with regular NAC (Virginia group, lead author Dr. Downes)

در قسمت صد و بیست و‌یکم‌دنتکست، مقاله ی جدید ی رو شروع میکنیم.این مقاله گایدلاینهای کلینیکی ای برای بازسازی دندانهای خلفی ارائه میدهاین گایدلاینها در مورد اینه که با توجه به میزان تخریب، دندونها به چه شکل و با چه نوع رستوریشنی بازسازی بشنمقاله ی جدید و جالبیه ،حتما گوش‌کنید.

Dr. Charlene Compher, PhD, RD, LDN, FADA, FASPEN, is a Professor of Nutrition Science at the University of Pennsylvania School of Nursing, and Advanced Practice Clinical Dietitian Specialist with the Clinical Nutrition Support Service at the Hospital of the University of Pennsylvania, where she works with the home parenteral nutrition team and dietetics research. Dr. Her volunteerism includes Chair of DNS in 2013, Editor in Chief of ASPEN's Clinical Guidelines 2008-2014, and President of ASPEN 2017-2018.  Dr. Compher is also a core leader with the Global Leadership Initiative on Malnutrition and recently led a systematic review of validation of the Academy- ASPEN Indicators of Malnutrition (AAIM).  She earned a Bachelor of Arts degree at the University of Tennessee followed by both Master and Doctoral degrees at Drexel University. This episode is hosted by Christina M. Rollins, MBA, MS, RDN, LDN, FAND, CNSC as was recorded on 9/7/23.

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers depression in children and adolescents with Dr. Darren Courtney, a scientist with the Cundill Centre for Child and Youth Depression and the Margaret and Wallace McCain Centre for Child, Youth and Family Mental Health and a staff psychiatrist in the Youth Addictions and Concurrent Disorders Service at the Centre for Addiction and Mental Health (CAMH) in Toronto. He is also an associate professor in the Department of Psychiatry at the University of Toronto.   Dr. Courtney earned his MD in 2004 at Queen's University and completed psychiatry residency in 2009 at the University of Ottawa. He was the clinical director of the Youth Inpatient Unit at the Royal Ottawa Mental Health Centre from 2009 to 2014 and moved to Toronto in 2014, where he worked on the Concurrent Youth Inpatient Unit at the Centre for Addiction and Mental Health until 2017 and where his clinical work with concurrent disorders continues now with outpatient youth.   Dr. Courtney's research focus is on the treatment of adolescent depression through the use of an integrated care pathway — a collaboratively developed treatment algorithm based on high-quality clinical practice guidelines. Through his research, he works on identifying quality practice guidelines and corresponding multi-disciplinary care pathways to facilitate evidence-based and measurement-based care for adolescents with depression. He has also participated in a systematic review and quality appraisal of clinical practice guidelines for psychiatric disorders in children and adolescents. Additionally, he has an interest in the management of concurrent disorders, where young people are affected by both primary psychiatric disorders and substance use disorders.   The learning objectives for this episode are as follows:   By the end of this episode, you should be able to… Outline the prevalence and risk factors for depression in children and adolescents Explain how children and adolescents with depression present in clinical practice Discuss the use of screening tools for depression in this population Describe an approach to the management of depression in children and adolescents Outline the management of an adolescent with suicidal thoughts or behaviours   Guest: Dr. Darren Courtney Hosts: Kate Braithwaite (MD) and Nikhita Singhal (PGY5) Audio editing by: Nikhita Singhal Show notes by: Kate Braithwaite and Nikhita Singhal   Interview Content: Introduction - 0:00 Learning objectives - 02:11 Prevalence of depression in youth - 03:11 Risk factors for depression in youth - 06:25 Diagnosing depression in youth - 08:30 Screening tools - 14:24 Approach to taking a history from youth - 19:45 Management of depression in youth - 30:12 Psychotherapies - 33:20 Medications - 37:37 Assessing and managing suicidality in youth - 44:00 Measurement based care - 51:00 Final thoughts - 55:10   Resources: Previous PsychEd episodes: PsychEd Episode 1: Diagnosis of Depression with Dr. Ilana Shawn PsychEd Episode 2: Treatment of Depression with Dr. Sidney Kennedy PsychEd Episode 18: Assessing Suicide Risk with Dr. Juveria Zaheer ICHOM Set of Patient-Centered Outcome Measures for Children & Young People with Depression & Anxiety Screening tools/rating scales: Revised Children's Anxiety and Depression Scale (RCADS) Mood and Feelings Questionnaire (MFQ) NICE guideline: Depression in children and young people: identification and management NICE guideline: Self-harm: assessment, management and preventing recurrence The CARIBOU Pathway by CAMH: A youth-centered program for the treatment of depression Includes links to download free clinician-specific and youth-specific resources co-developed with youth and mental health clinicians Clinical Innovations and Tools | Cundill Centre for Child and Youth Depression | CAMH Includes links to various tools for health care providers, researchers, youth, and other stakeholders (such as teachers and family members) informed by research evidence   References: Bennett K, Courtney D, Duda S, Henderson J, Szatmari P. An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depress Anxiety. 2018 Jun;35(6):530-540. https://doi.org/10.1002/da.22752 Courtney D, Bennett K, Henderson J, Darnay K, Battaglia M, Strauss J, Watson P, Szatmari P. A Way through the woods: Development of an integrated care pathway for adolescents with depression. Early Interv Psychiatry. 2020 Aug;14(4):486-494. https://doi.org/10.1111/eip.12918 Georgiades K, Duncan L, Wang L, Comeau J, Boyle MH; 2014 Ontario Child Health Study Team. Six-Month Prevalence of Mental Disorders and Service Contacts among Children and Youth in Ontario: Evidence from the 2014 Ontario Child Health Study. Can J Psychiatry. 2019 Apr;64(4):246-255. https://doi.org/10.1177%2F0706743719830024 Goodyer IM, Reynolds S, Barrett B, Byford S, Dubicka B, Hill J, Holland F, Kelvin R, Midgley N, Roberts C, Senior R, Target M, Widmer B, Wilkinson P, Fonagy P. Cognitive-behavioural therapy and short-term psychoanalytic psychotherapy versus brief psychosocial intervention in adolescents with unipolar major depression (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled trial. Health Technol Assess. 2017 Mar;21(12):1-94. https://doi.org/10.3310/hta21120 Hetrick SE, McKenzie JE, Bailey AP, Sharma V, Moller CI, Badcock PB, Cox GR, Merry SN, Meader N. New generation antidepressants for depression in children and adolescents: a network meta-analysis. Cochrane Database Syst Rev. 2021 May 24;5(5):CD013674. https://doi.org/10.1002/14651858.CD013674.pub2 MacQueen GM, Frey BN, Ismail Z, Jaworska N, Steiner M, Lieshout RJ, Kennedy SH, Lam RW, Milev RV, Parikh SV, Ravindran AV; CANMAT Depression Work Group. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly. Can J Psychiatry. 2016 Sep;61(9):588-603. https://doi.org/10.1177%2F0706743716659276 National Institute for Health and Care Excellence. Depression in children and young people: Identification and management NG134 [Internet]. London: NICE; 2019 Jun 25 [cited 2023 Sep 22]. Available from: https://www.nice.org.uk/guidance/ng134. Parikh A, Fristad MA, Axelson D, Krishna R. Evidence Base for Measurement-Based Care in Child and Adolescent Psychiatry. Child Adolesc Psychiatr Clin N Am. 2020 Oct;29(4):587-599. https://doi.org/10.1016/j.chc.2020.06.001 Walter HJ, Abright AR, Bukstein OG, Diamond J, Keable H, Ripperger-Suhler J, Rockhill C. Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Major and Persistent Depressive Disorders. J Am Acad Child Adolesc Psychiatry. 2023 May;62(5):479-502. https://doi.org/10.1016/j.jaac.2022.10.001 Wiens K, Bhattarai A, Pedram P, Dores A, Williams J, Bulloch A, Patten S. A growing need for youth mental health services in Canada: examining trends in youth mental health from 2011 to 2018. Epidemiol Psychiatr Sci. 2020 Apr 17;29:e115. https://doi.org/10.1017%2FS2045796020000281 World Health Organization. Mental health of adolescents [Internet]. 2021 [cited 2023 Sep 22]. Available from: https://www.who.int/news-room/fact-sheets/detail/adolescent-mental-health   CPA Note: The views expressed in this podcast do not necessarily reflect those of the Canadian Psychiatric Association. For more PsychEd, follow us on Twitter (@psychedpodcast), Facebook (PsychEd Podcast), and Instagram (@psyched.podcast). You can provide feedback by email at psychedpodcast@gmail.com. For more information, visit our website at psychedpodcast.org.

Episode 145: Family Planning for the LGBTQIA+Future Dr. Hoque explains how to assist with family planning for the LGBTQIA+ community. Some principles such as avoiding unintended pregnancies and reducing and early treatment of STIs are discussed.  Written by Ashfi Hoque, MBA, MS4, Ross University School of Medicine. You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Arreaza: Welcome to episode 145 of the Rio Bravo qWeek podcast. My name is Hector Arreaza, a faculty member of the Rio Bravo Family Medicine Residency Program.Ashfi: Hello everyone, I am Ashfi Hoque a 4th-year medical student at Ross University School of Medicine. I am from Long Beach, California. Patient advocacy and patient-centered care have always been a priority of mine. I've volunteered for years at the LGBT+ center in Weho and Long Beach. Today we will be discussing Family Planning for everyone while learning ways to become LGBTQIA+ inclusive. Arreaza: Yes, family planning is important, and I'm glad you included all types of families. I believe medical care must be offered to everyone, and I also believe in freedom of conscience, that's why I can freely express that I support traditional family for me. Why did you choose this topic?Ashfi: I chose this topic because my partner recently went to get her physical. Her provider had an extensive conversation about family planning and even discussed the anticipated cost of freezing her oocytes. I really loved the way this provider went about the conversation so I started researching ways I can support my community and also teach others to provide Queer inclusive medical care. What is LGBTQIA+?LGBTQIA+ stands for Lesbian, Gay, Bisexual, Trans, Queer, Intersex, Asexual, etc. The community will be referenced as the Queer community, an umbrella term for people who are not heterosexual or not cisgender. There are many inequalities that the community faces and we can do our due diligence to educate ourselves continuously and be aware that terminology and health needs may change. We have another Rio Bravo episode, Caring for LGBTQ+ Patients on Episode 103, that discusses healthcare disparities, but during this episode, we will be diving into an introduction to bridging health gaps, creating health equity, and building trust with the community. A 2023 Global Survey found that the self-identified Queer community represents 9% of the population, while the true estimate may be higher due to safety concerns. While diabetics are 10-13% of the population. These statistics show that as a medical provider, you'll encounter Queer patients more often than you think. One of the healthcare issues that Queer folks face is a lack of family planning.What is Family Planning?The World Health Organization (WHO) defines family planning as “the ability of individuals and couples to anticipate and attain their desired number of children and the spacing and timing of their births. It is achieved through the use of contraceptive methods and the treatment of involuntary infertility.”Family planning serves three critical needs: Avoiding unintended pregnanciesReducing sexually transmitted diseases (STDs)Early treatment of STDs to reduce rates of infertilityWhen discussing family planning for patients, here are some examples of questions you can ask. What name may I use to address you?What are your pronouns?What is your gender? (Only if necessary for care, what is your assigned sex at birth?)Are you sexually active?What is the gender(s) of your partner(s)?Are you concerned about unintended pregnancy?Are you currently using any contraceptive measures?Are you taking any precautions to reduce STI/STD such as physical barriers like condoms, dental dams, or any harm reduction such as PrEP?What kind of STI/STD screening are you requesting?Do you need me to request additional labs such as oral or anal swabs?Those questions must be asked in a natural, non-judgmental way. While STD/STI screening and treatment is part of family planning, the part that we tend to neglect is the desire for Queer folks to build a family. Why is Family Planning Important for the LGBTQIA+ community?The Queer community gained the legal right to marry eight years ago, in 2015. They did not have the nationwide right to adopt until the last state, Mississippi, overturned the unconstitutional restrictions for the Queer community to adopt in 2016. A UCLA study in 2018 titled, “How many same-sex couples in the US are raising children?” reported cis-heterosexual couples: 3% are raising at least one adopted child and 95% are raising biological children while same-sex couples: 21.4% are raising at least one adopted child and 68% have a biological child. When it comes to family planning, there is more than adoption for Queer people. Queer folks are not offered the same pregnancy planning options, such as cis hetero-couples who are experiencing infertility or cis-women planning for advanced maternal age pregnancy. However, the options are quite similar. These options require specific types of planning, and that information can be provided to patients by their primary care doctor. A couple needs to know their options and consider the long-term financial planning necessary for surrogacy, in vitro fertilization (IVF), or donor insemination. The main difference for many Queer couples is the method of conception needed. Depending on sexual orientation and gender identity, patients may have varying reproductive needs as part of their family planning. We cannot make assumptions about how family planning should look and need to remember this journey looks different from person to person and couple to couple.How to approach family planning with the LGBTQIA+ community? Basic tenants of providing medical care for queer patients: Clinics specializing in Queer family planning found patient-centered care leads to better outcomes. The best approach is to be mindful, conscious, and to communicate without assumptions. We have to start with providers building trust, being honest, showing sensitivity assisting with reproductive services, and working towards being more knowledgeable about Queer parenthood. A provider could ask questions such as: Would you like information about family planning?What do you imagine your future family to look like?Would you like to see options and potential costs?Would you need a referral for a specialist?Or it can be as simple as being honest about your scope of knowledge by stating, “I am not well versed in LGBTQIA+ community issues but what ways can I support you?” It is ethically appropriate to transition care to a physician with better knowledge if you feel unable to assist a person from the LGBTQ+ community. Make sure to do it in a polite and respectful way.Gender inclusive: With more people openly identifying as non-binary and trans, there is a need for a gender-neutral approach to discussing a patient's biological and reproductive needs. First, we will avoid assuming gender identity based on the biological sex of a patient. Episode 14 of Rio Bravo does a great job of breaking down gender diversity and the difference between gender identity and biological sex. For transgender and nonbinary patients, providing care for medical transitioning often includes conversations about family planning before starting HRT. It is common to ask patients about to begin HRT if they would like to freeze their sperm or eggs. Second, we want to avoid assuming anything based on what reproductive organs a patient has. We can ask a patient about their intention to start a family. Avoid asking if a trans patient has received transitional surgery (bottom surgery) unless it is completely necessary for the care we are providing. Instead, it is appropriate to ask the patient if birthing is an option? Have you given birth before? Were there any complications? Is there any current hormonal treatment? This mindful strategy is also useful for patients who may have limitations in: producing oocytes or sperm, the ability to house a fetus in utero, or implantation and fertility. Third, we are going to address our underlying beliefs and assumptions about gendered parenthood. Parenthood is almost always thought of as motherhood and fatherhood, but this can be alienating for transgender patients. There are many possible ways of being a parent, and to be inclusive let's consider the possibility of a masculine woman or transmasculine man being a birthing parent or of a transgender woman being the mother of a child without giving birth to the child. There are many more scenarios we can discuss at another point. In the interest of time, we are going to shift into discussing family planning for lesbian and gay people and couples. Sexuality inclusive:For homosexual cis-gendered people who are single or in relationships, family planning can look similar to couples facing infertility issues. When having family planning conversations with these patients, a provider should ask broad, unassuming questions. If you have established that a queer person or couple wants a child, then you can ask if they have a family plan. If the patient or couple has a plan, follow the couple's lead. If the patient(s) do not have a plan, then you can begin to ask questions like: Do you have someone in mind to be a birth giver? Do you have a sperm donor? Do you have an egg donor? These questions are a great transition into discussing the following options for family planning.What are the options for having a newborn and the financial and ethical cost?Having a child can cost up to $100k, and this does not even include the cost of childcare. Infertility treatment is not covered by regular insurance, so patients need either infertility insurance or private financing to cover the cost of treatment. However, fertility insurance does not cover same-sex couples. There is a large emotional, physical, and ethical cost to deciding which route to choose. Let's discuss options and obstacles.1. Donor Insemination: The most affordable route is having a birth-giving parent who is fertile with a known sperm donor. This method can be as simple as using a syringe to inseminate the uterus-carrying person, but we need to consider necessary attorney fees to terminate the parental rights of the sperm donor. Sperm from a sperm bank requires an extensive workup including STD panel, HIV, and genetic disorder screening. The sperm donor gives up all parental rights during the process. The price of these procedures is constantly changing and depends on location.California Cryobank costs start at $1200 for anonymous donors and $1900 for identification disclosure donor which the child will receive information about the donor at age 18. Selecting a donor can include specifics such as race, talents, education, hobbies, physical attributes, and showing donor baby photos. There are two common insemination processes:Intracervical insemination: semen inside the cervical opening and covers the cervixIntrauterine insemination: semen is inserted through the cervix and placed directly into the cavityThe next option jumps up in cost significantly.2. Freezing Eggs (Oocyte Cryopreservation):Pacific Fertility Center Los Angeles, reports a single cycle of egg freezing can cost $6-10k per freezing cycle and may need multiple cycles without medication. The medications are typically around $3-6k depending on how much your body needs. Storage is an additional cost of $700-$1,000 a year. This is an option for parents planning pregnancy during advanced ages.3. In Vitro Fertilization (IVF): It is a process where an oocyte is collected similarly to freezing eggs but fertilized with a partner's or donor's sperm.Pacific Fertility Center Los Angeles reports it costs $8-13k per cycle of fertilization. It is an option for those who have issues with infertility, previous pelvic inflammatory diseases, surgeries, and issues with implantations.4. Surrogacy: This is the process of hiring a professional birthing surrogate to carry an embryo. This is an alternative option for couples who decline or cannot carry a pregnancy. The surrogate has no legal rights or biological relation to the fetus. Family Tree Surrogacy reports it costs about $45-65k.5. Adoption: Foster care adoption in California can be $1-5k. American Cost of Adoption, reports the cost of adoption for infants in California $40-70k including the medical expenses for the birth-giving person and legal expenses for the process. Versus adopting an infant from another country due lack of resources and poverty may better their lives or cause a higher demand for infants which may be an ethical issue. Also, transcultural adoption where the race of the parents and the children are different, and navigating culture and race with the children. Adoptees have reported having racial identity crises.With all these studies, it is well documented that providers will not be perfect at giving care to the Queer community. These studies do not represent every queer person and do not take the intersectionality of race, class, or gender identity into consideration. It is our job as providers to be supportive of all types of patients in order to increase their access to proper medical care. _______________Conclusion: Now we conclude episode number 145, “Family Planning for the LGBTQIA+.” Future Dr. Hoque explained how queer people can be included in family planning conversations, even before heterosexual couples. She described some options such as donor insemination, freezing eggs, IVF, and adoption. Dr. Arreaza explained that it is important to ask reproductive questions in a natural, non-judgmental way to all your patients, and refer to another professional when needed. This week we thank Hector Arreaza and Ashfi Hoque. Audio editing by Adrianne Silva.Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:American Adoptions—How Much Does a Private Adoption Cost in California? [And Why?]. (n.d.). Retrieved July 14, 2023, fromhttps://www.americanadoptionsofcalifornia.com/adopt/cost-of-adoption-in-californiaAmerican Adoptions—LGBTQ Adoption: Can Same-Sex Couples Adopt? (n.d.). Retrieved July 14, 2023, fromhttps://www.americanadoptions.com/adopt/LGBT_adoptionCarpenter, E. (2021). “The Health System Just Wasn't Built for Us”: Queer Cisgender Women and Gender Expansive Individuals' Strategies for Navigating Reproductive Health Care. Women's Health Issues, 31(5), 478–484.https://doi.org/10.1016/j.whi.2021.06.004Choosing the Right Sperm Donor | California Cryobank. (n.d.-a). Retrieved July 14, 2023, from HTTPS://www.cryobank.com/how-it-works/choosing-your-donor/Choosing the Right Sperm Donor | California Cryobank. (n.d.-b). Retrieved July 14, 2023, from HTTPS://www.cryobank.com/how-it-works/choosing-your-donor/Cost of Egg & Embryo Freezing in the U.S. | PFCLA. (n.d.). Retrieved July 14, 2023, fromhttps://www.pfcla.com/blog/egg-freezing-costs. (2012, April 25).Donor Insemination. American Pregnancy Association.https://americanpregnancy.org/getting-pregnant/donor-insemination/Hollingsworth, L. D. (2003). International adoption among families in the United States: Considerations of social justice. Social Work, 48(2), 209–217.https://doi.org/10.1093/sw/48.2.209In vitro fertilization (IVF): MedlinePlus Medical Encyclopedia. (n.d.). Retrieved July 14, 2023, fromhttps://medlineplus.gov/ency/article/007279.htmIngraham, N., Fox, L., Gonzalez, A. L., & Riegelsberger, A. (2022a). “I just felt supported”: Transgender and non-binary patient perspectives on receiving transition-related healthcare in family planning clinics. PLOS ONE, 17(7), e0271691.https://doi.org/10.1371/journal.pone.0271691Ingraham, N., Fox, L., Gonzalez, A. L., & Riegelsberger, A. (2022b). “I just felt supported”: Transgender and non-binary patient perspectives on receiving transition-related healthcare in family planning clinics. PLOS ONE, 17(7), e0271691.https://doi.org/10.1371/journal.pone.0271691Ingraham, N., & Rodriguez, I. (2022a). Clinic Staff Perspectives on Barriers and Facilitators to Integrating Transgender Healthcare into Family Planning Clinics. Transgender Health, 7(1), 36–42.https://doi.org/10.1089/trgh.2020.0110Ingraham, N., & Rodriguez, I. (2022b). Clinic Staff Perspectives on Barriers and Facilitators to Integrating Transgender Healthcare into Family Planning Clinics. Transgender Health, 7(1), 36–42.https://doi.org/10.1089/trgh.2020.0110Klein, D. A., Malcolm, N. M., Berry-Bibee, E. N., Paradise, S. L., Coulter, J. S., Keglovitz Baker, K., Schvey, N. A., Rollison, J. M., & Frederiksen, B. N. (2018). Quality Primary Care and Family Planning Services for LGBT Clients: A Comprehensive Review of Clinical Guidelines. LGBT Health, 5(3), 153–170.https://doi.org/10.1089/lgbt.2017.0213PFCLA. (n.d.). The Cost of IVF in California. Retrieved July 14, 2023, fromhttps://www.pfcla.com/blog/ivf-costs-californiaPODCAST. (n.d.). Rio Bravo Residency. Retrieved July 14, 2023, fromhttps://www.riobravofmrp.org/qweek/episode/fcb76527/episode-103-caring-for-lgbtq-patientsRotabi, K. S. (n.d.). From Guatemala to Ethiopia: Shifts in Intercountry Adoption Leaves Ethiopia Vulnerable for Child Sales and Other Unethical Practices.Smoley, B. A., & Robinson, C. M. (2012). Natural Family Planning. American Family Physician, 86(10), 924–928.Surrogate Compensation | How Much Do Surrogater Paid in CA? (n.d.). Https://Familytreesurrogacy.Com/. Retrieved July 14, 2023, fromhttps://familytreesurrogacy.com/blog/surrogate-pay-california/The National Academies Press. (n.d.). Retrieved July 14, 2023, fromhttps://nap.nationalacademies.org/thisisloyal.com, L. |. (n.d.). How Many Same-Sex Couples in the US are Raising Children? Williams Institute. Retrieved July 14, 2023, fromhttps://williamsinstitute.law.ucla.edu/publications/same-sex-parents-us/Royalty-free music used for this episode: "Rain in Spain." Downloaded on October 13, 2022, from https://www.videvo.net/ 

Dr. Faisel and Dr. Dan are discussing Empowered Choices Bridging the Gap between Clinical Guidelines and Informed Decisions on this episode of Faisel & Friends! Our conversation revolves around the structures that allow us to spend more time with patients, the need for more in-depth drug trials, and the difference between evidence-based medicine and evidence-informed care.Being a doctor is your calling because you couldn't imagine doing anything else. Let's talk about your career goals in medicine. Connect with us and tell us how you dream of practicing medicine. Want to learn more about how we do healthcare? Visit our resource center and check out how we are transforming healthcare. Don't forget to subscribe to ChenMed Rx to receive the latest news and articles from ChenMed.

Evidence Behind Oncology Accelerated Approvals in Clinical Guidelines with guests Drs. Maryam Mooghali and Reshma Ramachandran July 2, 2023 Yale Cancer Center visit: http://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

Evidence Behind Oncology Accelerated Approvals in Clinical Guidelines with guests Drs. Maryam Mooghali and Reshma Ramachandran July 2, 2023 Yale Cancer Center visit: http://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

“Evidence-based practice is asking the right clinical question, searching the evidence and then really appraising and determining what is the quality of the evidence, and synthesizing it to move forward with a recommendation or a possible implementation plan,” Caroline Clark, MSN, APRN, OCN®, AG-CNS, director of evidence-based practice and inquiry at ONS, told Jaime Weimer, MSN, RN, AGNCS-BC, AOCNS®, oncology clinical specialist at ONS, during a discussion about the nurse's role in evidence-based oncology care. You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hour of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by February 24, 2025. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: The learner will report an increase in knowledge related to evidence-based practice. Episode Notes Complete this evaluation for free NCPD. ONS Evidence-Based Practice Learning Library ONS Voice articles: Real-World Usage Reports Show That ONS Guidelines™ Empower Nurses to Provide Best Patient Care Evidence-Based Practice Gives Oncology Nurses Knowledge and Standards for Clinical Care From Evidence to Standard: The Role of Clinical Guidelines in Oncology Care Overcome Barriers to Applying an Evidence-Based Process for Practice Change Adopt an Evidence-Based Practice Model to Facilitate Practice Change Strengthen a Commitment to Practice Change Through EBP Immersions The Difference Between Quality Improvement, Evidence-Based Practice, and Research Nursing evidence-based practice topic tag Clinical Journal of Oncology Nursing articles: Evidence-Based Practice in Oncology Nursing: Oncology Nursing Society Survey Results Success Is Not Final: Onward to the Future of Evidence-Based Practice Oncology Nursing Forum article: Measuring Clinical Decision Support Influence on Evidence-Based Nursing Practice ONS Biomarker Database The Ohio State University College of Nursing course: EBP Basics National Institutes of Health: Evidence-based practices, programs, and resources National Cancer Institute: Evidence-based cancer control programs Healthy People 2030 National Comprehensive Cancer Network American Society of Clinical Oncology To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From Today's Episode “Evidence-based practice (EBP) is asking the right clinical question, searching the evidence and then really appraising and determining what is the quality of the evidence, and synthesizing it to move forward with a recommendation or a possible implementation plan.” Timestamp (TS) 01:56 “Having a culture and environment that supports EBP is really foundational. An environment that encourages questions is going to cultivate the mentors in that environment and has leadership support. And often, that means tying EBP into your whole organizations mission and vision just to sustain evidence-based changes.” TS 06:15 “Developing your skills in critical appraisal does take time. It's not something that happens overnight, so you have to look for the opportunities to practice. Mentorship is certainly important. . . . Many organizations have adopted an EBP methodology, so while there's a lot of methodologies out there to choose from, there's so much overlap in them and the tools they use. I would really just explore if there's something already preferred in your organization.” TS 13:18 “Some key players to ask around about EBP are your nursing professional development specialists, your clinical nurse specialists, your DNP-prepared nurses, and your nurse scientists. And a great, low-risk way to practice critical appraisal is through journal clubs.” TS 13:57 “I think there's a lot of great work going on with the overarching theme of closing that gap from research to translation into practice. Some general things that I think are happening are really incorporating evidence into daily practice. That could be clinical decision support tools that are embedded in our electronic health record and then physicians, nurses, and clinicians have that at their fingertips at the point of care. And then standardized policies and templates to guide care for specific populations. And I think the use of religiously developed practice guidelines that are current at the point of care, as well.” TS 22:20 “If you're embarking on EBP change early on—I cannot stress this enough—you really need to determine what your outcome measures will be. How are things measured and recorded in the literature? How would you apply them in your practice? . . . From the start, consider specifically what the patient outcomes will be that you're monitoring that you're hoping to make a positive change in.” TS 31:12

Drs. Ravi Kalhan and Sidney S. Braman discuss COPD and some of its overlap syndromes including asthma-COPD overlap (ACO) and COPD-bronchiectasis, as well as controversies regarding their definitions, diagnosis, prognosis, monitoring and treatment despite lack of clinical guidelines.

For February 2023, the American Academy of Pediatrics published Clinical Guidelines for the Evaluation and Treatment of Children and Adolescents with Obesity.  As dietitians who work with children and adolescents who struggle with their relationship with food, body and well-being, we had to talk about this. You can download handouts discussed in the episode here: Don't Talk about Weight card Questions for Providers Below you will find links to our private practice websites so you can learn even more about us and our services. Non-Diet Wellness, LLC Paradine Shift

In this episode of What's Up Wednesday, obesity specialist and host, Karli Burridge, reviews the brand-new, first-ever Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity released by the American Academy of Pediatrics (AAP).FROM THE AMERICAN ACADEMY OF PEDIATRICS| CLINICAL PRACTICE GUIDELINE| JANUARY 09 2023Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity  by Sarah E. Hampl, MD, FAAP et alExecutive Summary: Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With ObesityObesity-focused Organizations Issue Statement in Support of New AAP Clinical Guideline on Childhood ObesitySupport the showThe Gaining Health Podcast will release a new episode monthly, every second Wednesday of the month. Episodes including interviews with obesity experts as well as scientific updates and new guidelines for the management of obesity.If you're a clinician or organization looking to start or optimize an obesity management program, and you want additional support and resources, check out the Gaining Health website! We offer monthly and annual Memberships, which include live group coaching, a community forum to ask questions and post resources, pre-recorded Master Classes, digital resources inlcuding patient education materials and office forms, and much more! We also sell our popular Gaining Health products, including a book on developing an obesity management program, editable forms and templates, and patient education materials in our Gaining Health Shop! If you are loving this podcast, please consider supporting us on Patreon

As they were gearing up for the Symposium for Metabolic Health in Boca Raton (https://www.lowcarbusa.org/smhp-symposiums/) - their 18th conference over the past eight incredible years - they decided to celebrate their 100th episode of the LowCarbUSA® Podcast with a look back at how they got here. In Episode 100, they talk about how they first learned about the low-carb/ketogenic lifestyle, and how they got the idea to organize the first Symposium for Metabolic Health in 2016. They also discuss the creation of the Clinical Guidelines (https://thesmhp.org/clinical-guidelines/), the formation of the Society of Metabolic Health Practitioners (The SMHP), the free resources available from both LowCarbUSA and The SMHP, the Metabolic Health Practitioner (MHP) accreditation process (https://thesmhp.org/membership-account/membership-levels/), and much more, including many of their hopes and dreams for the future! After the very first conference in San Diego, in 2016, we really started to realize how much this meant for the healthcare professional. And we really knew that's where we wanted to focus and make sure that healthcare professionals were aware of this information, first of all, and second of all, that there were conferences and training where they could come to learn all about it.

Dr. Jason Galster is a recognized leader in hearing loss and cochlear implants. He currently serves as the Director of Clinical Research at Advanced Bionics, a company that offers advanced cochlear implants for adults and children alike. He's also an adjunct professor at Salus University and Nova Southeastern University. Starting his career in 1999 as a research assistant, Dr. Galster is known for his innovation and research in audiology. He refined his approach over the course of a decade at Starkey Hearing Technologies, working as the Senior Manager of Audiology Research. In this episode… Clinical guidelines have a greater effect on the culture of audiology than many people realize. Setting a high watermark and standards of practice gives clinics defined goals, and the thorough process of establishing guidelines ensures they are realistic and applicable. Now that they've been issued, the refining process begins. Dr. Jason Galster is a key figure in the audiology world and has worked with the American Academy of Audiology (AAA) to continue pushing clinical guidelines. The use of the current standards helps experts know what is working well and what needs further improvement. So what should people expect for the future of guidelines? In this episode of the ListenUp! Podcast, Dr. Mark Syms invites Dr. Jason Galster, the Director of Clinical Research at Advanced Bionics, back onto the show to talk about improving clinical guidelines. They go through cochlear implant reimbursement and how it has changed through research. They also discuss the differences in pediatric and adult guidelines, defining terminology, and what the future holds for the AAA.

Between the beginning of the COVID-19 pandemic and May 2022, more than 527 million cases of SARS-CoV-2 have been confirmed. COVID-19 represents an ongoing challenge to the field of neurology, as neurologic complications of the disease are leading to an increase in demand for both acute and long-term neurologic evaluation and management. Three experts from Northwestern Medicine Neurology — Igor J. Koralnik, MD, Eric M. Liotta, MD, and Edith L. Graham, MD — have been investigating the pathogenic mechanisms of acute and long-term COVID-19, as they may inform clinical evaluation and management. They discuss their guideline "Therapeutic Approaches to the Neurologic Manifestations of COVID-19," published in Neurotherapeutics in July 2022.

Infants in the NICU are patients that require specialized care with unique clinical considerations. Specific recommendations must be considered for all systems of NICU patients and the skin is not any different. Infants who are being cared for in the NICU, especially those that were born premature have an increased risk for skin trauma. On this episode, we review some of the skin care guidelines and recommendations available for clinical practice of NICU patients. As NICU clinicians, is is important to not only be aware of the anatomical variations of a term and preterm infant's skin, but to also know how that guides their clinical care and treatment plan. Many of the topics we cover on this episode have been standards of care for years, but there are also new recommendations for practice and products available based on recent research findings. NICU clinicians will hear a great review as well as up-to-date clinical recommendations for skin care of our specialized population in the NICU. The episode will also be beneficial for parents to hear the clinical practice guidelines and recommendations for term and preterm infants as well as some of the variations that may exist between different institutions. Our NICU Roadmap: A Comprehensive NICU Journal: https://empoweringnicuparents.com/nicujournal/NeoTech Free Samples: neotechneoshades.comNICU Mama Hats: https://empoweringnicuparents.com/hats/NICU Milestone Cards: https://empoweringnicuparents.com/nicuproducts/Empowering NICU Parents Show Notes: https://empoweringnicuparents.com/episode35Empowering NICU Parents Instagram: https://www.instagram.com/empoweringnicuparents/Empowering NICU Parents FB Group: https://www.facebook.com/groups/empoweringnicuparentsPinterest Page: https://pin.it/36MJjmH

1999 ME/CFS Conference with harmful Clinical Guidelines for treatment, 2008 ME/CFS Conference interview with Dr Stephen Graves, 2022 talk by Dr Richard Loeffel on the need for new Clinical Guidlines for ME/CFS, Produced by Ian Woolf Support Diffusion by making a contribution Support Diffusion by buying through affiliate links

This episode demystifies clinical medical care ‘best practices' — clinical guidelines & outcome measures. These are regularly created, validated & updated, by expert teams and organizations. This rigorous, evidence-based process provides the USA with a quality and up to date clinical health care system.  [261 characters].   Guest:  John L. Gore, M.D. Professor of Urology, Professor of Surgery, Health Services Researcher, University of Washington. Urologist, surgeon, clinician, researcher, educator and expert in clinical care guidelines and outcomes. Dr. Gore is the PI of a large pragmatic trial in bladder cancer, and a quality of care expert. He previously served as the American Urological Association (AUA) representative to the National Quality Forum, which endorses national health care performance measures, and has been on guidelines panels for the National Comprehensive Cancer Network (NCCN) for kidney cancer, and the AUA for bladder cancer.   Resources: Avedis Donabedian — author of a classic core framework for evaluating the quality of medical care, laid out 50 years ago; the basis of our system today. This link is to a recent article about Donabedian and his work, and is helpful for understanding how and why outcome measures and clinical guidelines are needed and beneficial for quality health care. American Urological Association (AUA) Guidelines for Urology Care — find current health care guidelines for prostate conditions, bladder cancer, erectile dysfunction, etc. National Quality Forum  (NQF)— nonprofit US organization that sets standards for quality health care, and provides other services that advance quality health care. National Committee for Quality Assurance (NCQA)— nonprofit US organization that works to improve health care quality through the administration of evidence-based standards, measures, programs, and accreditation. Agency for Health Care Research and Quality (AHRQ) — lead US Federal agency charged with improving the safety and quality of healthcare for all Americans. AHRQ develops the knowledge, tools, and data needed to improve the healthcare system and help consumers, healthcare professionals, and policymakers make informed health decisions   Podcast Webstie & Social Media: Podcast Website: theoriginalguidetomenshealth.org Facebook Page: https://www.facebook.com/theoriginalguidetomenshealth/ Twitter: https://twitter.com/guide2menshlth LinkedIn: https://www.linkedin.com/company/the-original-guide-to-mens-health/

The European Respiratory Society has provided 8 conditional recommendations for the use of nasal high flow/high flow nasal cannula/high flow oxygen/whatever you want to call it. Here, I review the 8 recommendations and add some commentary on them. Show Notes: https://eddyjoemd.com/high-flow/ Citation: Oczkowski S, Ergan B, Bos L, Chatwin M, Ferrer M, Gregoretti C, Heunks L, Frat JP, Longhini F, Nava S, Navalesi P, Ozsancak Uğurlu A, Pisani L, Renda T, Thille AW, Winck JC, Windisch W, Tonia T, Boyd J, Sotgiu G, Scala R. ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure. Eur Respir J. 2022 Apr 14;59(4):2101574. doi: 10.1183/13993003.01574-2021. PMID: 34649974. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/eddyjoemd/support

"We need to address the underlying preventable factors that cause more Black Americans to die of heart attacks and strokes and suffer from high blood pressure and diabetes complications than white Americans instead of focusing on non-existent biological differences. I would like to see the scientific disciplines unite to call out the mislabeling of race as a biological category and stop using race in place of structural racism, toxic stress caused by discrimination, and systemic inequities in social determinants of health. Instead of emphasizing our biological differences, the research community needs to focus on the real problems Black Americans continue to face that increase their risk of illness and death." Carmen Presti is a nurse practitioner. She shares her story and discusses her KevinMD article, "Remove race from clinical guidelines." Did you enjoy today's episode? Rate and review the show so more audiences can find The Podcast by KevinMD. Subscribe on your favorite podcast app to get notified when a new episode comes out. Reflect and earn 1.0 AMA PRA Category 1 CME for this episode. Also available in Category 1 CME bundles. Powered by CMEfy - a seamless way for busy clinician learners to discover Internet Point-of-Care Learning opportunities that reward AMA PRA Category 1 Credit(s)™. Learn more at about.cmefy.com/cme-info

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers interpersonal psychotherapy (IPT) with Dr. Paula Ravitz, an Associate Professor of Psychiatry at the University of Toronto and Senior Clinician-Scientist at the Lunenfeld-Tanenbaum Research Institute of Mt Sinai Hospital. Dr. Ravitz held the Morgan Firestone Psychotherapy Chair at the Mount Sinai Hospital from 2011 to 2021 and is a past president of the International Society of Interpersonal Psychotherapy. The learning objectives for this episode are as follows:   By the end of this episode, you should be able to… Define interpersonal psychotherapy Describe the core principles and phases of IPT Become familiarized with some psychological theories underpinning IPT List some patient selection considerations for IPT Describe the efficacy and evidence base for IPT  Understand how IPT is practically carried  out  Briefly compare and contrast IPT to other common psychotherapies   Guest: Dr. Paula Ravitz (paula.ravitz@sinaihealthsystem.ca)   Hosts: Jake Johnston and Sena Gok   Audio editing by: Jake Johnston   Show notes by: Jake Johnston   Interview Content: Introduction - 00:00 Learning objectives - 02:10 Definition/overview of IPT - 02:53 Core principles and phases - 07:20 Psychological theories - 19:30 Patient selection considerations - 24:42 Contraindications - 35:57 Evidence base and history - 38:10 Practical components of IPT - 43:57 Maintenance IPT - 59:52 IPT vs other psychotherapies - 62:56  Closing comments - 71:17 Online IPT course - 74:30   Resources: Summary of IPT written in layman's terms: https://www.camh.ca/en/health-info/mental-illness-and-addiction-index/interpersonal-psychotherapy The International Society of Interpersonal Psychotherapy (ISIPT) has a helpful overview of IPT and helpful resources for finding more information and IPT training opportunities: https://interpersonalpsychotherapy.org/ ‘Psychotherapy Essentials to Go' book series mentioned during episode:  https://www.penguinrandomhouse.ca/series/CNL/psychotherapy-essentials-to-go Course for learning IPT mentioned at the end of the episode (email Dr. Ravitz at Paula.Ravitz@sinaihealth.ca to inquire about access): www.learnipt.com     References: Bernecker, S. L., Coyne, A. E., Constantino, M. J., & Ravitz, P. (2017). For whom does interpersonal psychotherapy work? A systematic review. Clinical psychology review, 56, 82–93. https://doi.org/10.1016/j.cpr.2017.07.001 Chaimowitz, G., Weerasekera, P., & Ravitz, P. (2021). Psychotherapy in Psychiatry. The Canadian Journal of Psychiatry, 66(11), 999–1004. https://doi.org/10.1177/07067437211040958 Cuijpers, P., Donker, T., Weissman, M. M., Ravitz, P., & Cristea, I. A. (2016). Interpersonal Psychotherapy for Mental Health Problems: A Comprehensive Meta-Analysis. The American journal of psychiatry, 173(7), 680–687. https://doi.org/10.1176/appi.ajp.2015.15091141  Dennis, C. L., Grigoriadis, S., Zupancic, J., Kiss, A., & Ravitz, P. (2020). Telephone-based nurse-delivered interpersonal psychotherapy for postpartum depression: nationwide randomised controlled trial. The British journal of psychiatry : the journal of mental science, 216(4), 189–196. https://doi.org/10.1192/bjp.2019.275  Elkin, I., Shea, M. T., Watkins, J. T., Imber, S. D., Sotsky, S. M., Collins, J. F., Glass, D. R., Pilkonis, P. A., Leber, W. R., & Docherty, J. P. (1989). National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Archives of general psychiatry, 46(11), 971–983. https://doi.org/10.1001/archpsyc.1989.01810110013002 Klerman, G. L., Dimascio, A., Weissman, M., Prusoff, B., & Paykel, E. S. (1974). Treatment of depression by drugs and psychotherapy. The American journal of psychiatry, 131(2), 186–191. https://doi.org/10.1176/ajp.131.2.186  MacQueen, G. M., Frey, B. N., Ismail, Z., Jaworska, N., Steiner, M., Lieshout, R. J., Kennedy, S. H., Lam, R. W., Milev, R. V., Parikh, S. V., Ravindran, A. V., & CANMAT Depression Work Group (2016). Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 61(9), 588–603. https://doi.org/10.1177/0706743716659276 Parikh, S. V., Quilty, L. C., Ravitz, P., Rosenbluth, M., Pavlova, B., Grigoriadis, S., Velyvis, V., Kennedy, S. H., Lam, R. W., MacQueen, G. M., Milev, R. V., Ravindran, A. V., Uher, R., & CANMAT Depression Work Group (2016). Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological Treatments. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 61(9), 524–539. https://doi.org/10.1177/0706743716659418 Ravitz, P., & Watson, P. (2014). Interpersonal Psychotherapy: Healing with a Relational Focus. FOCUS, 12(3), 275-284. https://doi.org/10.1176/appi.focus.12.3.275 Ravitz, P., Watson, P., Lawson, A., Constantino, M. J., Bernecker, S., Park, J., & Swartz, H. A. (2019). Interpersonal Psychotherapy: A Scoping Review and Historical Perspective (1974-2017). Harvard review of psychiatry, 27(3), 165–180. https://doi.org/10.1097/HRP.0000000000000219 Swartz, H. (2021). Interpersonal Psychotherapy (IPT) for depressed adults: Indications, theoretical foundation, general concepts, and efficacy. UpToDate. Accessed 2021-10-12.   CPA Note: The views expressed in this podcast do not necessarily reflect those of the Canadian Psychiatric Association.   For more PsychEd, follow us on Twitter (@psychedpodcast), Facebook (PsychEd Podcast), and Instagram (@psyched.podcast). You can provide feedback by email at psychedpodcast@gmail.com. For more information, visit our website at psychedpodcast.org.  

Iboga (or its extraction ibogaine) is one of the most powerful psychedelic plants. Today we are joined by Jonathan Dickinson, of Ceiba Recovery, an integration coach and consultant for iboga and ibogaine healing. Our conversation begins with an overview of iboga and its unique value in treating addiction. We discuss Bwiti tradition in Gabon and Central Africa, where iboga is used as an initiatory sacrament. Jonathan shares his work with Ceiba Recovery, which includes online ibogaine aftercare. We conclude with the pros and cons of a clinical ibogaine setting vs the traditional iboga initiation, as well as general advice on integrating this powerful medicine. Jonathan is a recovery coach and consultant and has been working with iboga and ibogaine in both clinical and ceremonial contexts in Canada, Mexico, and Costa Rica since 2009. He has been part of hundreds of detox treatments and has also coached people through long-term micro-dosing protocols for everything from depression and anxiety to neurodegenerative disorders. He previously served as the Director of the Global Ibogaine Therapy Alliance (GITA), during which time he led the development of the Clinical Guidelines for Ibogaine-Assisted Detoxification, a risk management guide that remains a standard in the field. Links Ceiba Recovery Clinical Guidelines for Ibogaine-Assisted Detoxification The Global Ibogaine Therapy Alliance (GITA) Blessings of the Forest Timestamps :07 - What is iboga and what does the experience feel like? :16 - Iboga as a sacrament for initiation :27 - Jonathan's process from initial interest to aftercare coaching and support of iboga :32 - Protecting the local community and sustainable farming in Gabon :34 - Ceiba, addiction, and the stages of change model :44 - Iboga in a clinical setting vs traditional initiation :50 - Dealing with Iboga's long integration

Therapeutic carbohydrate restriction is no longer a fringe practice and is now increasingly recognized for its value in diabetes, obesity, neurodegenerative disease, stroke, heart disease, dementia, and some cancers. Clinical guidelines and a standard of care about the practice will help accelerate this change.  Doug Reynolds is the Founder and CEO of LowCarbUSA® and President of the Society of Metabolic Health Practitioners(SMHP).  The Society of Metabolic Health Practitioners (SMHP) is a non-profit for practitioners focused on metabolic health and they have a panel of advisors to oversee the creation and maintenance of a set of 'Clinical Guidelines for Therapeutic Carbohydrate Restriction'. The SMHP also helps to establish Standard of Care around carbohydrate restriction.LowCarbUSA provides a platform for scientists and medical practitioners to present the ever-increasing body of evidence on the benefits of reducing carbohydrates in the diet and adding in healthy fats. It has now evolved into one of the primary resources for the low carb community.   https://thesmhp.org/https://www.lowcarbusa.org/ #longevity #wellness  #Ketones #lifestylemedicine #younger #ketosis #biohacking #acetone #RobertLufkinMD #metabolichealth #dougreynolds  #societyofmetabolichealthpractitioners #lowcarbusa*** CONNECT WITH ROBERT LUFKIN MD ON SOCIAL MEDIA ***Web: https://robertlufkinmd.com/ Twitter:https://twitter.com/robertlufkinmdYoutube: https://www.youtube.com/RobertLufkinMD*** GOT A SUGGESTION FOR A SHOW? ***Contact us at: https://robertlufkinmd.com/contact *** SPONSORSHIPS & BRANDS ***We do work with sponsors and brands. If you are interested in working with us for your health industry product or service, please contact us at: https://robertlufkinmd.com/contact  NOTE: This is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have. Never disregard professional medical advice or delay in seeking it because of something you have seen here. Robert Lufkin MD may at any time and at its sole discretion change or replace the information available on this channel. To the extent permitted by mandatory law, Robert Lufkin MD shall not be liable for any direct, incidental, consequential, indirect or punitive damages arising out of access to or use of any content available on this channel, including viruses, regardless of the accuracy or completeness of any such content.Disclaimer: We are ambassadors or affiliates for many of the brands we reference on the channel.